Canadian Investors: 3 Top TSX Stocks for December

The Canadian stock market has hosted some truly incredible stocks in recent decades. Some have returned more than 10,000%, while others have increased their dividends for 30 years straight. Whether you prefer growth, income, or both, the TSX has a stock for you. This fall, several notable TSX stocks have gone on sale. This month could be your last chance…

Read More

Green Organic Dutchman (TSX:TGOD) Stock Is Now Too Cheap to Ignore!

Green Organic Dutchman Holdings (TSX:TGOD) was once one of the best-performing cannabis stocks on the market. In its first 30 days of trading, shares nearly doubled. In 2018, it surpassed a $1 billion market cap. This year, the story reversed course. Since March, Green Organic stock has shed 80% of its value. Of course, most other cannabis stocks have been…

Read More

Should Aurora Cannabis (TSX:ACB) Stock Be on Your 2020 Buy List?

The meltdown in the shares prices of Canadian marijuana stocks is attracting contrarian investors searching for potential big winners in 2020. Pot stocks are now trading near their 12-month lows, after a rough earnings season that saw many of the companies scale back revenue projections amid ongoing challenges in the recreational market. The rollout of legal recreational pot in Canada…

Read More

3 Growth Stocks Ready to Double in 2020

If you want to double your money in 2020, this is your chance. For the upcoming year, Canada has some of the most promising growth stocks on the market. They’re not without risk, but the upside potential is clear. Each stock listed below has already proven an ability to double in value. If you look at the fundamentals, there’s reason…

Read More

Here’s Why Canopy Growth (TSX:WEED) Is Still a Top Cannabis Stock

Canopy Growth (TSX:WEED)(NYSE:CGC) continues to be one divisive stock. While the cannabis space has its staunch bears and its equally vocal bulls, nowhere is the divide more stark than among Canopy observers. Even a casual glance over the past week’s headlines for the stock shows just how volatile its tickers have been in only a short amount of time. Canopy…

Read More

Why Aurora Cannabis (TSX:ACB) Stock Fell 13.53% Last Friday

Aurora Cannabis (TSX:ACB)(NYSE:ACB) had an epic one-day loss last week, falling 13.53% from its Thursday closing price to its Friday closing price. The losses came after months of bad news for the cannabis industry, ranging from CannTrust’s Health Canada scandal to Canopy’s $1.23 billion loss. Aurora itself has not been the biggest disaster among cannabis companies; nevertheless, its stock has been among the biggest…

Read More

Can Cannabis Stocks Make New TFSA Millionaires Again?

Following the Canadian marijuana industry has been quite an experience since late 2016, the stocks’ price volatility needed someone with nerves of steel to resist dumping positions during bloodbaths, but some new TFSA millionaires were undoubtedly made over the past three years when capital gains topped 600% more than once. Falling in love with an aggressive Aurora Cannabis (TSX:ACB)(NYSE:ACB) early…

Read More

Why Did HEXO (TSX:HEXO) Cannabis Stock Jump 38%?

HEXO (TSX:HEXO)(NYSE:HEXO) stock has been in trouble. Since April, shares have shed 75% of their value. This once multi-billion-dollar stock is now being valued at just $750 million. HEXO isn’t alone. The entire industry has experienced intense pain this year. Most cannabis ETFs are down at least 50%. Nearly every pot stock has been crushed. Yet the pain could finally…

Read More

$100 Billion Tobacco Giant Altria (NYSE:MO) Just Bet Big on This Cannabis Stock

The cannabis industry has been hit hard in recent months, with popular marijuana-based ETFs down 50% or more. Yet recent actions from $100 billion tobacco behemoth Altria Group (NYSE:MO) could signal a bottom. On November 20, Altria purchased four million shares of Cronos Group (TSX:CRON)(NASDAQ:CRON), adding to its existing position in the company. Notably, the purchases follow a steep 70%…

Read More

Bank of America (NYSE:BAC) Says This Cannabis Stock Is Now a Buy

Bank of America analysts haven’t always been bullish on cannabis stocks, but due to the recent industry-wide decline, they’re jumping in. On November 20, the firm upgraded shares of Canopy Growth (TSX:WEED)(NYSE:CGC) to “buy,” noting that consensus estimates are finally “achievable (even beatable).” A big part of the upgrade was valuation. Since April, Canopy shares have lost two-thirds of their…

Read More